Kenneth Brinkhous
From Wikipedia, the free encyclopedia
Kenneth Merle Brinkhous | |
|---|---|
| Born | May 29, 1908 |
| Died | December 11, 2000 (aged 92) |
| Citizenship | US |
| Alma mater | University of Iowa |
| Known for | Research in Pathology & Hematology |
| Scientific career | |
| Fields | Medicine & Pathology |
Kenneth Merle Brinkhous (1908–2000) was a professor and chairperson in the Department of Pathology and Laboratory Medicine at the University of North Carolina at Chapel Hill. Brinkhous remained active in research until shortly before his death.
Brinkhous graduated from the University of Iowa Medical School with an M.D. in 1932 and trained in the specialty of pathology there. His mentor, Dr. Harry P. Smith, led a training program that combined clinical aspects of pathology and laboratory research, the latter focusing on aspects of blood coagulation. While in Iowa, Dr. Brinkhous carried out research on hemophilia as part of a research team that included several other physicians interested in coagulation. Brinkhous made the seminal discovery of antihemophilic factor (Factor VIII) and showed that it was lacking in hemophiliac patients.
His research in Iowa was disrupted by World War II. During that conflict, Dr. Brinkhous commanded an Army laboratory in Australia, which served as a reference facility for the U. S. military forces in the South Pacific. After the war he returned to Iowa, but did not remain there long.
Career at the University of North Carolina
In 1946, Brinkhous accepted the chairmanship of pathology at the University of North Carolina (UNC), and held that position until 1973. During his tenure, the department evolved from a two-faculty section, without a strong research presence, into a widely recognized research department. Brinkhous also developed a high quality of teaching and clinical service. He had a leading role in planning and implementing the pathology laboratories for the North Carolina Memorial Hospital that opened in 1952. Brinkhous was influential in the development and staffing of an expanded medical school faculty at UNC, especially in its clinical departments. His philosophy was that excellent teaching and clinical service required associated research programs of high quality.[citation needed]
Brinkhous developed a coagulation research program at UNC, which stressed team efforts between researchers who worked in concert but from different perspectives. Throughout his career, Dr. Brinkhous recruited local students to research, many of whom became renowned scientists in their own right. He was an outstanding mentor, who combined friendship and personal concern with a demand for persistent, intense effort. Contributions made by coagulationists at UNC included the demonstration that hemophilia could be controlled by administering plasma containing Factor VIII, and the development of methods to purify and concentrate Factor VIII for use as a therapeutic agent. The partial thromboplastin test was also developed, as now used in hospital laboratories around the world. The team also investigated Von Willebrand disease, and studied the effects of snake venom on blood clotting. That work led to the use of proteases in treating victims of vascular thrombosis.
